Royal Bank Of Canada Blueprint Medicines Corp Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Royal Bank Of Canada holds 8,932 shares of BPMC stock, worth $839,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,932

Previous 17,004 47.47%

Holding current value

$839,072

Previous $1.57 Million 50.45%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $665,778 - $818,420	-8,072 Reduced 47.47%	8,932 $779,000
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $682,976 - $978,580	8,121 Added 91.42%	17,004 $1.57 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $374,451 - $478,196	4,396 Added 97.97%	8,883 $957,000
Q1 2024 Nov 05, 2024	SELL	$73.17 - $99.79 $321,655 - $438,676	-4,396 Reduced 49.49%	4,487 $425,000
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $1.25 Million - $1.7 Million	-17,042 Reduced 79.16%	4,487 $425,000
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $459,645 - $970,735	10,456 Added 94.43%	21,529 $1.99 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $195,760 - $275,484	4,174 Added 60.5%	11,073 $556,000
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $18,610 - $29,269	441 Added 6.83%	6,899 $436,000
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $219,580 - $289,150	-5,783 Reduced 47.24%	6,458 $290,000
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $348,968 - $565,013	8,499 Added 227.12%	12,241 $536,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $49,430 - $76,923	-990 Reduced 20.92%	3,742 $246,000
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $128,769 - $199,717	-2,847 Reduced 37.56%	4,732 $239,000
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $556,851 - $1.13 Million	-10,293 Reduced 57.59%	7,579 $484,000
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $828,646 - $1.02 Million	8,792 Added 96.83%	17,872 $1.91 Million
Q3 2021 Nov 15, 2021	SELL	$80.98 - $109.47 $1.38 Million - $1.86 Million	-17,031 Reduced 65.23%	9,080 $934,000
Q2 2021 Aug 16, 2021	BUY	$82.78 - $101.0 $2.16 Million - $2.64 Million	26,111 New	26,111 $2.3 Million

Others Institutions Holding BPMC

# of Institutions

373

Shares Held

65.1M

Call Options Held

2.25M

Put Options Held

1.01M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.61B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Blueprint Medicines Corp Transaction History